These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study. Procopio F; Viganò L; Cimino M; Donadon M; Del Fabbro D; Torzilli G Eur J Surg Oncol; 2020 May; 46(5):818-824. PubMed ID: 31839435 [TBL] [Abstract][Full Text] [Related]
9. Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: Should surgical strategy be influenced by tumor biology? Rhaiem R; Duramé A; Primavesi F; Dorcaratto D; Syn N; Rodríguez ÁH; Dupré A; Piardi T; Fernández GB; Villaverde AP; Rodríguez Sanjuán JC; Santiago RF; Fernández-Moreno MC; Ferret G; Ben SL; Suárez Muñoz MÁ; Perez-Alonso AJ; Koh YX; Jones R; Martín-Pérez E; Kianmanesh R; Di Martino M Surgery; 2024 Jul; 176(1):124-133. PubMed ID: 38519408 [TBL] [Abstract][Full Text] [Related]
10. Not All Kirsten Rat Sarcoma Viral Oncogene Homolog Mutations Predict Poor Survival in Patients With Unresectable Colorectal Liver Metastasis. Lin Z; Liu Y; Cai S; Yang C; Zhou L; Li W Technol Cancer Res Treat; 2021; 20():15330338211039131. PubMed ID: 34669528 [No Abstract] [Full Text] [Related]
11. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis. Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246 [TBL] [Abstract][Full Text] [Related]
12. The ALPPS Approach for Colorectal Liver Metastases: Impact of KRAS Mutation Status in Survival. Serenari M; Alvarez FA; Ardiles V; de Santibañes M; Pekolj J; de Santibañes E Dig Surg; 2018; 35(4):303-310. PubMed ID: 29032374 [TBL] [Abstract][Full Text] [Related]
13. Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases. Frankel TL; Vakiani E; Nathan H; DeMatteo RP; Kingham TP; Allen PJ; Jarnagin WR; Kemeny NE; Solit DB; D'Angelica MI Cancer; 2017 Feb; 123(4):568-575. PubMed ID: 27737491 [TBL] [Abstract][Full Text] [Related]
14. RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases. Okuno M; Goumard C; Kopetz S; Vega EA; Joechle K; Mizuno T; Omichi K; Tzeng CD; Chun YS; Vauthey JN; Conrad C Ann Surg Oncol; 2018 Aug; 25(8):2457-2466. PubMed ID: 29786130 [TBL] [Abstract][Full Text] [Related]
15. Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Kokudo N; Tada K; Seki M; Ohta H; Azekura K; Ueno M; Matsubara T; Takahashi T; Nakajima T; Muto T Am J Surg; 2001 Feb; 181(2):153-9. PubMed ID: 11425058 [TBL] [Abstract][Full Text] [Related]
16. KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases. Kemeny NE; Chou JF; Capanu M; Gewirtz AN; Cercek A; Kingham TP; Jarnagin WR; Fong YC; DeMatteo RP; Allen PJ; Shia J; Ang C; Vakiani E; D'Angelica MI Cancer; 2014 Dec; 120(24):3965-71. PubMed ID: 25155157 [TBL] [Abstract][Full Text] [Related]
17. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival. Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128 [TBL] [Abstract][Full Text] [Related]
18. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Vauthey JN; Zimmitti G; Kopetz SE; Shindoh J; Chen SS; Andreou A; Curley SA; Aloia TA; Maru DM Ann Surg; 2013 Oct; 258(4):619-26; discussion 626-7. PubMed ID: 24018645 [TBL] [Abstract][Full Text] [Related]
19. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases. Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912 [TBL] [Abstract][Full Text] [Related]
20. Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome? Lalmahomed ZS; Ayez N; van der Pool AE; Verheij J; IJzermans JN; Verhoef C World J Surg; 2011 Mar; 35(3):656-61. PubMed ID: 21161655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]